Qlife Holding ABOSTO:QLIFE -4.89%15 Net Current Asset Value is kr-0.09 as of Mar. 2026. GuruFocus rates OSTO:QLIFE with a GF Score™ of 15/100 and a GF Value™ of kr0.76 (Significantly Overvalued). The stock has 9 warning signs investors should review. Among 569 Medical Devices & Instruments companies, Qlife Holding AB ranks worse than 175746.75% on this metric.
In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).
Qlife Holding AB's net current asset value per share for the quarter that ended in Mar. 2026 was kr-0.09.
The historical rank and industry rank for Qlife Holding AB's Net Current Asset Value or its related term are showing as below:
During the past 7 years, the highest Price-to-Net-Current-Asset-Value Ratio of Qlife Holding AB was 677.07. The lowest was 2.89. And the median was 6.28.
OSTO:QLIFE's Price-to-Net-Current-Asset-Value is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 4.99 * Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only.
Qlife Holding AB (OSTO:QLIFE) Net Current Asset Value Explanation
Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."
The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]
Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.
One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Grahams strategy produced similar results.
Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.
Qlife Holding AB Net Current Asset Value Related Terms
Qlife Holding AB Net Current Asset Value Historical Data
* Premium members only.
The historical data trend for Qlife Holding AB's Net Current Asset Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:QLIFE vs ABT, SYK, MDT: Net Current Asset Value Comparison
For the Medical Devices subindustry, Qlife Holding AB's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Qlife Holding AB Price-to-Net-Current-Asset-Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Qlife Holding AB's Price-to-Net-Current-Asset-Value distribution charts can be found below:
* The bar in red indicates where Qlife Holding AB's Price-to-Net-Current-Asset-Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Net Current Asset Value of kr-0.09 mean?
Qlife Holding AB (OSTO:QLIFE) has a Net Current Asset Value of kr-0.09 as of Mar. 2026. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on Qlife Holding AB and its competitors. Over the past decade, Qlife Holding AB's Net Current Asset Value has ranged from 2.89 to 677.07. According to the industry distribution chart, Qlife Holding AB ranks #999999 out of 569 companies in the Medical Devices & Instruments industry.
Is Qlife Holding AB's Net Current Asset Value too high?
Qlife Holding AB's current Net Current Asset Value is kr-0.09. Over the past 10 years, this metric has ranged from a low of 2.89 to a high of 677.07. Based on the distribution chart, Qlife Holding AB ranks #999999 out of 569 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Qlife Holding AB has a GF Score™ of 15/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Qlife Holding AB's Net Current Asset Value compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Qlife Holding AB ranks #999999 out of 569 companies for Net Current Asset Value. This places Qlife Holding AB in the lower half of its industry. The industry median Net Current Asset Value is 4.99. Historically, Qlife Holding AB's own Net Current Asset Value has ranged from 2.89 to 677.07 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Current Asset Value for a Medical Devices & Instruments company?
The median Net Current Asset Value among Medical Devices & Instruments companies is 4.99, based on 569 companies in the industry. Companies in the top quartile (top 25%) have a Net Current Asset Value significantly above this median, while those in the bottom quartile fall well below. However, Net Current Asset Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Current Asset Value mean?
A high Net Current Asset Value can signal that a stock is expensive relative to its fundamentals. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on Qlife Holding AB and its competitors. For the Medical Devices & Instruments industry, the median Net Current Asset Value is 4.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Qlife Holding AB's current Net Current Asset Value is kr-0.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Qlife Holding AB stock overvalued right now?
Based on GuruFocus' analysis, Qlife Holding AB (OSTO:QLIFE) is currently considered Significantly Overvalued. The stock's GF Value™ is kr0.76, compared to a current price of kr1.83 — trading 140.5% above its estimated fair value. The current Net Current Asset Value is kr-0.09. Qlife Holding AB's overall GF Score™ is 15/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Current Asset Value calculated?
Net Current Asset Value is calculated from a company's financial statements. For Qlife Holding AB (OSTO:QLIFE), the current Net Current Asset Value is kr-0.09 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Qlife Holding AB (OSTO:QLIFE) Overvalued in 2026?
Based on GuruFocus' analysis, Qlife Holding AB stock appears to be overvalued.
The current stock price of kr1.83 is trading 140.5% above its estimated GF Value™ of kr0.76.
GuruFocus considers Qlife Holding AB to be Significantly Overvalued.
Key valuation signals for OSTO:QLIFE:
Net Current Asset Value: kr-0.09
GF Value™: kr0.76 vs. price of kr1.83 (140.5% above fair value)
No single metric tells the full story. See the OSTO:QLIFE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Qlife Holding AB is a medical device company that seeks to revolutionize the clinical biomarker testing of whole blood by taking it out of the lab and into the homes of the people who needs it. The Egoo Home System is an integrated platform consisting of a small home device and disposable capsules, each of which tests for a specific biomarker. It provides a digital infrastructure for sharing the data with the patient's doctor, clinic or hospital via smartphone and computer.
15GF Score
Get the complete analysis for OSTO:QLIFE
Net Current Asset Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:QLIFE has been successfully added to your 
